Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958)
NIS HELENA documented outcomes in clinical routine practice of first-line therapy with P plus T and docetaxel (D) of patients with advanced HER2-positive BC and prior (neo)adjuvant T.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 September 2022
|
| In: |
Breast cancer research and treatment
Year: 2022, Volume: 196, Issue: 2, Pages: 311-321 |
| ISSN: | 1573-7217 |
| DOI: | 10.1007/s10549-022-06710-4 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10549-022-06710-4 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s10549-022-06710-4 
|
| Author Notes: | Marc Thill, Pauline Wimberger, Andrea Grafe, Peter Klare, Kerstin Luedtke-Heckenkamp, Dietmar Reichert, Matthias Zaiss, Katja Ziegler-Löhr, Tanja Eckl, Andreas Schneeweiss |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1851052941 | ||
| 003 | DE-627 | ||
| 005 | 20230706222332.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230627s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10549-022-06710-4 |2 doi | |
| 035 | |a (DE-627)1851052941 | ||
| 035 | |a (DE-599)KXP1851052941 | ||
| 035 | |a (OCoLC)1389532563 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Thill, Marc |d 1969- |e VerfasserIn |0 (DE-588)120154129 |0 (DE-627)08048333X |0 (DE-576)292066694 |4 aut | |
| 245 | 1 | 0 | |a Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T |b results from a German non-interventional study (NIS) HELENA (NCT01777958) |c Marc Thill, Pauline Wimberger, Andrea Grafe, Peter Klare, Kerstin Luedtke-Heckenkamp, Dietmar Reichert, Matthias Zaiss, Katja Ziegler-Löhr, Tanja Eckl, Andreas Schneeweiss |
| 264 | 1 | |c 12 September 2022 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.06.2023 | ||
| 520 | |a NIS HELENA documented outcomes in clinical routine practice of first-line therapy with P plus T and docetaxel (D) of patients with advanced HER2-positive BC and prior (neo)adjuvant T. | ||
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Dual HER2 blockade | |
| 650 | 4 | |a HER2-positive | |
| 650 | 4 | |a Metastatic breast | |
| 650 | 4 | |a Pertuzumab | |
| 650 | 4 | |a Trastuzumab | |
| 700 | 1 | |a Wimberger, Pauline |d 1971- |e VerfasserIn |0 (DE-588)121614859 |0 (DE-627)705574733 |0 (DE-576)292800061 |4 aut | |
| 700 | 1 | |a Grafe, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klare, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Luedtke-Heckenkamp, Kerstin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reichert, Dietmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zaiss, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ziegler-Löhr, Katja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eckl, Tanja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Breast cancer research and treatment |d Dordrecht [u.a.] : Springer Science + Business Media B.V., 1981 |g 196(2022), 2, Seite 311-321 |h Online-Ressource |w (DE-627)320433722 |w (DE-600)2004077-5 |w (DE-576)104194162 |x 1573-7217 |7 nnas |a Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T results from a German non-interventional study (NIS) HELENA (NCT01777958) |
| 773 | 1 | 8 | |g volume:196 |g year:2022 |g number:2 |g pages:311-321 |g extent:11 |a Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T results from a German non-interventional study (NIS) HELENA (NCT01777958) |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10549-022-06710-4 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s10549-022-06710-4 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230627 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |d 50000 |e 910000PS109972554 |e 910400PS109972554 |e 50000PS109972554 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 10 |y j | ||
| 998 | |g 121614859 |a Wimberger, Pauline |m 121614859:Wimberger, Pauline |p 2 | ||
| 999 | |a KXP-PPN1851052941 |e 4343844064 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1851052941"],"doi":["10.1007/s10549-022-06710-4"]},"physDesc":[{"extent":"11 S."}],"title":[{"title_sort":"Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T","title":"Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T","subtitle":"results from a German non-interventional study (NIS) HELENA (NCT01777958)"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"12 September 2022"}],"relHost":[{"recId":"320433722","title":[{"title_sort":"Breast cancer research and treatment","title":"Breast cancer research and treatment"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2004077-5"],"issn":["1573-7217"],"eki":["320433722"]},"origin":[{"publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedKey":"1981","dateIssuedDisp":"1981-","publisher":"Springer Science + Business Media B.V. ; Kluwer"}],"language":["eng"],"part":{"volume":"196","year":"2022","text":"196(2022), 2, Seite 311-321","pages":"311-321","extent":"11","issue":"2"},"pubHistory":["1.1981 -"],"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T results from a German non-interventional study (NIS) HELENA (NCT01777958)Breast cancer research and treatment"}],"name":{"displayForm":["Marc Thill, Pauline Wimberger, Andrea Grafe, Peter Klare, Kerstin Luedtke-Heckenkamp, Dietmar Reichert, Matthias Zaiss, Katja Ziegler-Löhr, Tanja Eckl, Andreas Schneeweiss"]},"language":["eng"],"note":["Gesehen am 27.06.2023"],"person":[{"role":"aut","family":"Thill","display":"Thill, Marc","given":"Marc"},{"display":"Wimberger, Pauline","given":"Pauline","role":"aut","family":"Wimberger"},{"family":"Grafe","role":"aut","given":"Andrea","display":"Grafe, Andrea"},{"family":"Klare","role":"aut","given":"Peter","display":"Klare, Peter"},{"family":"Luedtke-Heckenkamp","role":"aut","display":"Luedtke-Heckenkamp, Kerstin","given":"Kerstin"},{"role":"aut","family":"Reichert","given":"Dietmar","display":"Reichert, Dietmar"},{"given":"Matthias","display":"Zaiss, Matthias","role":"aut","family":"Zaiss"},{"family":"Ziegler-Löhr","role":"aut","display":"Ziegler-Löhr, Katja","given":"Katja"},{"role":"aut","family":"Eckl","given":"Tanja","display":"Eckl, Tanja"},{"display":"Schneeweiss, Andreas","given":"Andreas","family":"Schneeweiss","role":"aut"}],"recId":"1851052941"} | ||
| SRT | |a THILLMARCWDUALHER2BL1220 | ||